Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Investigators report findings from the largest analysis characterizing objective imaging response among patients with mRCC treated in routine clinical practice.
Everolimus improved recurrence-free survival in patients with very high-risk disease but not in those with intermediate high-risk disease.
In a study of patients with mRCC, both TKI and PD-1 inhibitors displayed significant nephrotoxicity.
The median time to definitive deterioration was longer with lenvatinib-pembrolizumab than with sunitinib.
Updated guideline discusses advanced radiation therapy techniques and places emphasis on multidisciplinary care
Positive surgical margins in patients undergoing robotic partial nephrectomy for renal tumors are associated with adverse oncologic outcomes, a study revealed.
An interim analysis suggests that axitinib given to patients with complex clear cell renal cell carcinoma tumors significantly reduces tumor size and complexity.
Efforts to reduce obesity may cut the prevalence of these urological conditions.
While socioeconomic disparities are evident, survival differences between racial groups persist after RCC diagnosis.